1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Global Combined Hormonal Contraceptives (CHC) Market: Trends and Opportunities (2014-19)

Global Combined Hormonal Contraceptives (CHC) Market: Trends and Opportunities (2014-19)

  • January 2015
  • -
  • Daedal Research
  • -
  • 64 pages

Summary

Table of Contents

Search Inside

Scope of the Report

The report titled “Global Combined Hormonal Contraceptive (CHC) Market: Trends and Opportunities (2014-2019)” provides an in-depth analysis of the global CHC market with detailed analysis of market sizing and growth, market share and economic impact of the industry. The report also assesses key opportunities in the market and outlines the factors that are and will be driving growth of the industry. Growth of the overall CHC industry has also been forecasted for the period 2014-19, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. An insight into strategic issues affecting key brands on the market is provided followed by an analysis of the leading companies in the hormonal contraceptives market. The report also analyzes the key CHC products in pipeline.Further, key players of the industry like Agile Therapeutics; Bayer Healthcare; Teva Pharmaceuticals and Actavis PLC; are analyzed in the report.

Country Coverage

• United states
• United Kingdom
• India
• China
• Japan

Company Coverage

• Agile Therapeutics Inc.
• Actavis Plc.
• Bayer Healthcare
• Teva Pharmaceuticals

Executive Summary

Combined Hormonal Contraceptives (CHC) is widely being used as an effective and reversible birth control method. Mainly used for preventing pregnancies but sometimes also used for treating acne vulgaris, endometriosis, polycystic ovarian syndrome and irregular menstrual flow, CHC works by preventing ovulation i.e. release of egg from ovaries. The hormones are provided in the combined pill, patch or ring.

Most popular Combined Hormonal Contraceptives products are Nuvaring and Ortho Evra. CHC products are broadly used throughout the world by women in the age-group of 15 to 49 years. With increasing health consciousness and awareness, adoption of CHC products or birth control methods is increasing in lesser privileged economic segments too. The growth of CHC market is driven by urbanization and increasing user awareness, rise in menstruating population globally and initiatives taken by governments to encourage the use of contraception. Major trends prevailing in the market are the increasing number of mergers and acquisitions in this business space and demand for reversible method of contraception with fewer side effects.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global Contraceptives - Consumer Healthcare

Global Contraceptives - Consumer Healthcare

  • $ 4950
  • Industry report
  • January 2017
  • by Global Industry Analysts

This report analyzes the worldwide markets for Contraceptives in US$ by the following Contraception Methods: Hormonal Contraceptives (Oral Contraceptives, & Other Hormonal Contraceptives), and Condoms. ...

Global Intrauterine Contraceptive Devices Market - Growth, Trends and Forecasts (2017 - 2022)

Global Intrauterine Contraceptive Devices Market - Growth, Trends and Forecasts (2017 - 2022)

  • $ 4750
  • Industry report
  • January 2017
  • by Mordor Intelligence LLP

The Global Intra Uterine contraceptive Devices market is estimated to be USD 1,370 million in 2016 and is expected to reach USD 2,267 million by 2021, growing at a compound annual growth rate (CAGR) of ...

Global Contraceptive Pills Market - Growth, Trends and Forecasts (2017 - 2022)

Global Contraceptive Pills Market - Growth, Trends and Forecasts (2017 - 2022)

  • $ 4250
  • Industry report
  • February 2017
  • by Mordor Intelligence LLP

The global market for contraceptive pills is estimated to be USD 680 million in the year 2014. This market is expected to reach USD 1.03 billion by the end of 2019. During this period, the market is estimated ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market in the US

  • April 2017
    28 pages
  • Therapy  

  • United States  

View report >

Biguanide Market in India

  • April 2017
    3 pages
  • Biguanide  

    Dermatological ...  

  • India  

View report >

Therapy Market in the US

  • March 2017
    265 pages
  • Therapy  

    Cardiovascular ...  

    Risky Behaviour  

  • United States  

View report >

Related Market Segments :

Contraceptive

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.